Effectiveness of Non-invasive Neuromodulation for Intestinal Transit in Healthy Subjects
Objectives

Main objective:

Assess the effectiveness of non-invasive neuromodulation treatment (NESA) for the management of constipation in patients without diagnosed pathology in Spain

Secondary objectives:

Evaluate the improvement in sleep quality Analyze the improvement in blood pressure quality Measure the improvement in cortisol quality Determine if there is an improvement in heart rate
- EligibilityCriteria: Inclusion Criteria:  Participants from 18 to 65 years old Sign informed consent  Exclusion Criteria:  Diagnosed diseases at the time of the study. Severe previous psychiatric conditions. Medical contraindications that prevent the use of non-invasive neuromodulation therapy. Having exercised in the hours prior to the NESA treatment. Having consumed coffee or tobacco in the hours prior to the treatment. Minors. Individuals who have previously received any type of neuromodulation treatment. Cancer. - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 18 Years - MaximumAge: 65 Years - StdAgeList: Adult, Older Adult